Literature DB >> 103833

Experimental urinary tract infection with Pseudomonas aeruginosa in mice.

T Nishi, K Tsuchiya.   

Abstract

Urinary tract infection with Pseudomonas aeruginosa was induced in mice by transurethral inoculation of the organism into the bladder, followed by urethral obstruction for 6 h. The infection was mostly localized in the urinary organs. P. aeruginosa P9 was selected as the challenge organism from 10 laboratory strains of P. aeruginosa. After the inoculation of 10(7) colony-forming units of P. aeruginosa P9, transient bacteremia was observed in some of the mice from 6 h to 1 day after the inoculation. The number of organisms in the bladder tissue gradually decreased, whereas that in the kidneys increased to levels of 10(6) to 10(7) colony-forming units in 3 days, and these levels remained up to 2 weeks after the inoculation. The organisms gradually disappeared thereafter, and spontaneous recovery took place. The organisms could be recovered from the kidneys of 95% of the mice, and the gross lesions in the kidneys were observed in 77% of the mice 1 week after inoculation. The method developed here is simple and may be useful in the study of urinary tract infections due to P. aeruginosa and other species of bacteria.20

Entities:  

Mesh:

Year:  1978        PMID: 103833      PMCID: PMC422185          DOI: 10.1128/iai.22.2.508-515.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  EXPERIMENTAL PYELONEPHRITIS. ASCENDING INFECTION OF THE RAT KIDNEY BY ORGANISMS RESIDING IN THE URETHRA.

Authors:  R H HEPTINSTALL
Journal:  Br J Exp Pathol       Date:  1964-08

2.  EXPERIMENTAL PYELONEPHRITIS IN THE MOUSE PRODUCED BY ESCHERICHIA COLI, PSEUDOMONAS AERUGINOSA AND PROTEUS MIRABILIS.

Authors:  R H GORRILL; S J DENAVASQUEZ
Journal:  J Pathol Bacteriol       Date:  1964-01

3.  THE FATE OF PSEUDOMONAS AERUGINOSA, PROTEUS MIRABILIS AND ESCHERICHIA COLI IN THE MOUSE KIDNEY.

Authors:  R H GORRILL
Journal:  J Pathol Bacteriol       Date:  1965-01

4.  Bacterial localisation in the kidney with particular reference to Pseudomonas pyocyanea.

Authors:  R H GORRILL
Journal:  J Pathol Bacteriol       Date:  1952-10

5.  Experimental model of corynebacterium renale pyelonephritis produced in mice.

Authors:  E Shimono; R Yanagawa
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

6.  An in vivo pyelonephritis assay for screening therapeutic agents.

Authors:  E H Thiele
Journal:  J Antibiot (Tokyo)       Date:  1974-01       Impact factor: 2.649

7.  Experimental infection with Pseudomonas aeruginosa in mice. I. The virulence of Pseudomonas aeruginosa for mice.

Authors:  F Kobayashi
Journal:  Jpn J Microbiol       Date:  1971-07

8.  The incidence and nature of pyuria in experimental murine pyelonephritis: a re-appaisal of the Sternheimer-Malbin stain.

Authors:  D M Harris
Journal:  J Pathol Bacteriol       Date:  1968-07

9.  EXPERIMENTAL PYELONEPHRITIS: OBSERVATIONS ON MIXED INFECTION.

Authors:  H ROCHA; S S DEALMEIDA
Journal:  Yale J Biol Med       Date:  1965-02

10.  Pyelitis, an important factor in the pathogenesis of retrograde pyelonephritis.

Authors:  B R ANDERSEN; G G JACKSON
Journal:  J Exp Med       Date:  1961-09-01       Impact factor: 14.307

View more
  12 in total

1.  In vivo evaluation of NM441, a new thiazeto-quinoline derivative.

Authors:  M Ozaki; M Matsuda; Y Tomii; K Kimura; J Segawa; M Kitano; M Kise; K Shibata; M Otsuki; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

2.  Comparative activities of cefotiam and cefazolin against urinary tract infections with Proteus mirabilis in mice.

Authors:  T Iwahi; K Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

3.  Noninvasive biophotonic imaging for monitoring of catheter-associated urinary tract infections and therapy in mice.

Authors:  Jagath L Kadurugamuwa; Kshitij Modi; Jun Yu; Kevin P Francis; Tony Purchio; Pamela R Contag
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Urethral obstruction of 6 hours or less causes bacteriuria, bacteremia, and pyelonephritis in mice challenged with "nonuropathogenic" Escherichia coli.

Authors:  D E Johnson; R G Russell; C V Lockatell; J C Zulty; J W Warren
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.

Authors:  Y Iizawa; K Okonogi; R Hayashi; T Iwahi; T Yamazaki; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

6.  Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.

Authors:  Y Iizawa; T Nishi; M Kondo; K Tsuchiya; A Imada
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

7.  In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116.

Authors:  T Imada; S Miyazaki; M Nishida; K Yamaguchi; S Goto
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

8.  Enterococcus faecalis aggravates pyelonephritis caused by Pseudomonas aeruginosa in experimental ascending mixed urinary tract infection in mice.

Authors:  N Tsuchimori; R Hayashi; A Shino; T Yamazaki; K Okonogi
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

Authors:  L Hagberg; I Engberg; R Freter; J Lam; S Olling; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Pseudomonas urinary tract infection in mice.

Authors:  J Z Montgomerie; W J Tuddenham; E B Howard; J W Morrow
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.